Mirati Therapeutics reported $-188386000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Amgen AMGN:US $ 2727M 56M
Astellas Pharma 4503:JP Y -10516M 88833M
Biocryst Pharmaceuticals BCRX:US $ -73.92M 58.39M
Bluebird Bio BLUE:US $ -122.15M 10.09M
Bristol Myers Squibb BMY:US $ 5386M 595M
Eisai 4523:JP Y -20779M 34669M
Exelixis EXEL:US $ 85.23M 32.79M
IONIS PHARMACEUT IONS:US $ -64M 289M
Johnson & Johnson JNJ:US $ 8218M 1879M
Merk MRK:US $ 6309M 1525M
Moderna Inc MRNA:US 4.23B 1.18B
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Seattle Genetics SGEN:US $ -135.24M 41.73M
Takeda 4502:JP Y -54047M 126240M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
YTE INCY:US $ 172.84M 1.75M